Sean Maduck Corcept Therapeutics Inc (CORT) insider trading activity

Sean Maduck is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 8,179 shares of CORT, which is worth approximately $617,841. The most recent transaction as insider was on Dec 02, 2025, when has been sold 135 shares (Common Stock) at a price of $79.78 per share, resulting in proceeds of $10,770. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.18K

3.48% 3M change

90.41% 12M change

Total Value Held $617,841

Sean Maduck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2025	SELL Payment of exercise price or tax liability	$10,770 $79.78 p/Share	135 Reduced 1.62%	8,179 Common Stock
Dec 01 2025	SELL Open market or private sale	$1,590,400 $79.52 p/Share	20,000 Reduced 71.67%	7,904 Common Stock
Dec 01 2025	BUY Exercise of conversion of derivative security	$165,400 $8.27 p/Share	20,000 Added 41.75%	27,904 Common Stock
Dec 01 2025	BUY Grant, award, or other acquisition	$16,354 $39.89 p/Share	410 Added 4.7%	8,314 Common Stock
Nov 03 2025	SELL Open market or private sale	$1,479,800 $73.99 p/Share	20,000 Reduced 71.67%	7,904 Common Stock
Nov 03 2025	BUY Exercise of conversion of derivative security	$165,400 $8.27 p/Share	20,000 Added 41.75%	27,904 Common Stock
Oct 01 2025	SELL Open market or private sale	$1,695,800 $84.79 p/Share	20,000 Reduced 71.67%	7,904 Common Stock

Oct 01 2025	BUY Exercise of conversion of derivative security	$133,200 $6.66 p/Share	20,000 Added 41.75%	27,904 Common Stock
Sep 03 2025	SELL Payment of exercise price or tax liability	$16,631 $71.38 p/Share	233 Reduced 2.86%	7,904 Common Stock
Sep 02 2025	SELL Open market or private sale	$1,412,200 $70.61 p/Share	20,000 Reduced 72.25%	7,681 Common Stock
Sep 02 2025	BUY Grant, award, or other acquisition	$16,274 $35.69 p/Share	456 Added 5.31%	8,137 Common Stock
Sep 02 2025	BUY Exercise of conversion of derivative security	$101,000 $5.05 p/Share	20,000 Added 41.95%	27,681 Common Stock
Aug 01 2025	SELL Open market or private sale	$2,400,780 $68.58 p/Share	35,007 Reduced 82.01%	7,681 Common Stock
Aug 01 2025	BUY Exercise of conversion of derivative security	$176,785 $5.05 p/Share	35,007 Added 45.06%	42,688 Common Stock
Jul 18 2025	SELL Open market or private sale	$34,737 $73.44 p/Share	473 Reduced 2.6%	17,705 Common Stock
Jul 18 2025	BUY Exercise of conversion of derivative security	$2,388 $5.05 p/Share	473 Added 2.54%	18,178 Common Stock
Jul 17 2025	SELL Open market or private sale	$317,066 $73.48 p/Share	4,315 Reduced 19.6%	17,705 Common Stock
Jul 17 2025	BUY Exercise of conversion of derivative security	$21,790 $5.05 p/Share	4,315 Added 16.39%	22,020 Common Stock
Jul 01 2025	SELL Open market or private sale	$15,057 $73.45 p/Share	205 Reduced 1.14%	17,705 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	$1,035 $5.05 p/Share	205 Added 1.13%	17,910 Common Stock
Jun 12 2025	SELL Bona fide gift	-	10,024 Reduced 56.62%	7,681 Common Stock
Jun 02 2025	SELL Open market or private sale	$1,587,200 $79.36 p/Share	20,000 Reduced 53.04%	17,705 Common Stock
Jun 02 2025	BUY Grant, award, or other acquisition	$557,030 $25.58 p/Share	21,776 Added 36.61%	37,705 Common Stock
May 29 2025	SELL Bona fide gift	-	10,000 Reduced 38.57%	15,929 Common Stock
May 29 2025	BUY Exercise of conversion of derivative security	$38,800 $3.88 p/Share	10,000 Added 27.83%	25,929 Common Stock

Sean Maduck

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account